查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球牙周药物市场
市场调查报告书
商品编码
1272772

2023-2030 年全球牙周药物市场

Global Periodontal Therapeutics Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

全球牙周药物市场预计将在 2022 年达到 7.348 亿美元，并在 2030 年达到 614.593 亿美元，并实现利润丰厚的增长。 预计牙周病市场在预测期内（2023-2030 年）的复合年增长率为 9.2%。 使用抗生素后的辅助治疗将支持这一市场趋势。

牙周病的非手术治疗，包括使用抗菌产品和口腔深层清洁，已被证明足以在早期逆转牙周病。 局部和口服抗生素用于控制牙周炎症和牙菌斑。 口服抗生素放置在由微生物感染引起的牙龈和牙齿之间的空隙（通常称为牙周袋）。

牙龈疾病从轻微到严重不等，如果不及时治疗可能会导致牙齿脱落。 全球牙周药物市场的主要增长因素是人们对口腔卫生重要性的认识不断提高、人口老龄化以及新产品和新技术的开发。

市场动态

在预测期内，对更好的口腔健康的需求不断增长推动了牙周药物的全球市场增长

口腔卫生已成为保持身体健康的最重要参数之一。 因此，口腔卫生意识的增强正在推动牙周药物市场的发展，尤其是在发达国家。 世界卫生组织 (WHO) 表示，超过 5.3 亿儿童的乳牙患有龋齿。

宝洁 (Procter & Gamble) 和高露洁棕榄 (Colgate-Palmolive) 等领先公司致力于在儿童和成人中传播牙齿卫生意识，从而创造对牙周药物的需求。 由于口腔卫生意识的提高，预计全球牙周药物市场在预测期内将快速扩张。

抗生素的临床无效阻碍了牙周药物市场的增长

抗生素在治疗牙周病方面的部分无效一直是限制牙周药物市场增长的关键因素。 抗生素在治疗牙周病方面的应用受到限制，因为它们在治疗细菌感染和癒合牙周袋方面效果不佳，尤其是在严重牙周炎的晚期。

抗生素治疗主要与口腔手术和牙齿清洁程序结合使用。 此外，在疾病治疗中过度使用或滥用抗生素会导致抗菌素耐药性。 预计这些因素将阻碍预测期内牙周药物市场的增长。

COVID-19 影响分析

由于 COVID-19 的爆发，全球牙周药物市场不景气。 2020 年上半年，用于治疗牙周病的抗生素的销售增长略有下降。 这可能是由于牙科护理的医院就诊次数减少以及全球牙医的处方减少。

俄乌衝突分析

全球牙周治疗市场可能会受到俄罗斯和乌克兰之间持续衝突的间接影响。 多国因衝突对俄罗斯实施的经济制裁波及俄罗斯经济。 因此，包括牙周治疗市场在内的牙科保健行业可能会受到影响。

牙科设备是从俄罗斯进口和出口的，因此战争的影响可能会阻碍俄罗斯向其他国家供应牙科设备。 此外，辉瑞、拜耳和赛诺菲等主要製药公司推迟了在俄罗斯的新投资和开发，扰乱了药品供应链。 这些由衝突驱动的破坏正在对全球牙周药物市场产生负面影响。

了解有关此报告的更多信息 - 索取样本

内容

第一章调查方法及范围

  • 调查方法
  • 调查目的和范围

第 2 章定义和概述

第 3 章执行摘要

  • 按处理分类的片段
  • 按疾病类型分类的摘要
  • 按销售渠道
  • 区域摘要

第四章市场动态

  • 影响因素
    • 主持人
      • 在预测期内，对更好的口腔卫生需求的增长推动了全球牙周药物市场的增长
    • 约束因素
      • 抗生素的临床无效阻碍了牙周药物市场的增长
    • 机会
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 价格分析
  • 法律法规分析

第 6 章 COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情景
    • 当前的 COVID-19 情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格和动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第7章治疗

  • 全身性抗生素
  • 外用抗生素

第 8 章按疾病类型分类

  • 牙龈炎
  • 慢性牙周炎
  • 进行性牙周炎
  • 坏死性牙周病
  • 其他

第 9 章分销渠道

  • 零售药店和药店
  • 医院药房
  • 牙科诊所
  • 电子商务

第10章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第11章竞争格局

  • 竞争场景
  • 市场情况/份额分析
  • 併购分析

第12章公司简介

  • Kaken Pharmaceutical Co. Ltd.
    • 公司概况
    • 产品组合和说明
    • 财务摘要
    • 主要发展状况
  • Bausch Health
  • Colgate-Palmolive
  • Medicom
  • Pfizer Inc.
  • 3M
  • Den-Mat Holdings, LLC
  • Dentsply Sirona
  • Xttrium Laboratories, Inc.
  • Dexcel Pharma

第13章 附录

简介目录
Product Code: PH1888

Market Overview

The global periodontal therapeutics market reached US$ 734.8 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 61,459.3 million by 2030. The periodontal therapeutics market is expected to exhibit a CAGR of 9.2% during the forecast period (2023-2030). Adjuvant therapies following the use of antibiotics will support the trend in this market.

The non-surgical treatment procedures for gum disease include the use of antibacterial products and deep cleaning of the mouth which is proven to be sufficient for reversing the periodontal disease in its early stages. Antibiotics including both topical and oral are prescribed for the control of inflammation and plaque of the gum tissue. Oral antibiotics are placed in the gaps formed between gums and teeth by microbial infection, commonly called periodontal pockets.

Periodontal diseases can range from mild to severe and can cause tooth loss if left untreated. The major factors for growth of the global periodontal therapeutics market are the increasing awareness of the importance of oral health, the aging population, and the development of new products and technologies.

Market Dynamics

The increasing demand for better oral hygiene to drive global periodontal therapeutics market growth during the forecast period

Oral hygiene has become one of the most important parameters for staying healthy. Therefore, the growing awareness about oral hygiene is driving the periodontal therapeutics market, specifically in developed countries. The World Health Organization (WHO) states that over 530 million children suffer from dental caries of primary teeth.

Key players such as Procter & Gamble and Colgate-Palmolive Company have undertaken initiatives to spread awareness regarding dental hygiene, both for children and adults, creating demand for periodontal therapeutic drugs. Owing to rising awareness for better oral hygiene, the global periodontal therapeutics market will upscale at a rapid pace over the forecast period.

The clinical inefficiencies of antibiotics to hamper periodontal therapeutics market growth.

The partial inefficiency of antibiotics in the treatment of periodontal disease is a key factor limiting the growth of the periodontal therapeutics market. The use of antibiotics in the treatment of gum disease is limited, especially in the later stages of severe periodontitis owing to the low efficiency of treating bacterial infection and healing pockets.

Antibiotic treatment is mostly used in combination with oral surgery or dental cleaning procedures. Furthermore, the overuse and misuse of antibiotics in disease treatment may result in antimicrobial resistance. These factors are expected to hamper the periodontal therapeutics market growth over the forecast period.

COVID-19 Impact Analysis

The global periodontal therapeutics market has experienced a downturn due to the outbreak of COVID-19. In the first half of 2020, there was a slight decrease in the sales growth of antibiotics used for the treatment of periodontal disease. This can be attributed to a reduction in hospital visits for dental services and a decrease in prescriptions from dentists around the world.

Russia Ukraine Conflict Analysis

The global periodontal therapeutic market may be indirectly affected by the ongoing conflict between Russia and Ukraine. Economic sanctions imposed on Russia by several countries due to the conflict have led to repercussions in the Russian economy. As a result, the dental healthcare industry, including the periodontal therapeutic market, may be impacted.

The supply of dental equipment from Russia to other countries may be disrupted due to the war, as Russia both imports and exports dental equipment. Additionally, major pharmaceutical companies such as Pfizer, Bayer, and Sanofi have deferred new investments or developments in Russia, which has led to disruptions in the medicine supply chain. These disruptions caused by the conflict have had a negative impact on the global periodontal therapeutics market.

For more details on this report - Request For Sample

Segment Analysis

The global periodontal therapeutics market is segmented based on treatment, disease type, distribution channel, and region.

Gingivitis segment to hold the highest global periodontal therapeutics market share

The gingivitis segment is expected to dominate and account for 54.7% of the global periodontal therapeutics market share over the forecast period. Gingivitis is one of the most common types of periodontitis. This is usually caused by poor oral hygiene and red, swollen gums. They also tend to bleed easily.

The treatment of gingivitis focuses on reducing inflammation, removing plaque, and establishing good oral hygiene habits to prevent plaque build-up. Mouthwash, topical antibiotics, or antiseptics may be recommended. For more serious infections or periodontitis, the dentist may recommend oral antibiotics. For instance, over-the-counter medicated toothpaste, mouth rinses, and mouth sprays are very safe, provided they are used as directed. Therefore, this segment growth will boost the global periodontal therapeutics market growth over the forecast period.

Geographical Analysis

The presence of major players to dominate the North America region.

North America is expected to have a dominant global periodontal therapeutics market share of around 1/3rd of this market. The U.S. is the largest revenue contributor in North America, and the presence of a large dental workforce in this region indicates its dominance in the global market. For instance, according to the American Dental Association, as of 2022, there are 202,536 professionally active dentists in the U.S. There are 60.8 dentists per 100,000 U.S. population.

Competitive Landscape

The major global players in the market include Kaken Pharmaceutical Co. Ltd., Bausch Health, Colgate-Palmolive, Medicom, Pfizer Inc., 3M, Den-Mat Holdings, LLC, Dentsply Sirona, Xttrium Laboratories, Inc., and Dexcel Pharma.

Why Purchase the Report?

  • To visualize the global periodontal therapeutics- market segmentation based on treatment, disease type, distribution channel, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global periodontal therapeutics market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global periodontal therapeutics market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Treatment
  • 3.2. Snippet by Disease Type
  • 3.3. Snippet by Distribution Channel
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The increasing demand for better oral hygiene to drive global periodontal therapeutics market growth during the forecast period
    • 4.1.2. Restraints
      • 4.1.2.1. The clinical inefficiencies of antibiotics to hamper periodontal therapeutics market growth
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Treatment

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 7.1.2. Market Attractiveness Index, By Treatment
  • 7.2. Systemic Antibiotics
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Local Antibiotics

8. By Disease Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 8.1.2. Market Attractiveness Index, By Disease Type
  • 8.2. Gingivitis*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Chronic Periodontitis
  • 8.4. Aggressive Periodontitis
  • 8.5. Necrotizing Periodontal Disease
  • 8.6. Others

9. By Distribution Channel

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2. Market Attractiveness Index, By Distribution Channel
  • 9.2. Retail Pharmacies and Drug Stores*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Hospital Pharmacies
  • 9.4. Dental Clinics
  • 9.5. E-Commerce

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Kaken Pharmaceutical Co. Ltd.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Bausch Health
  • 12.3. Colgate-Palmolive
  • 12.4. Medicom
  • 12.5. Pfizer Inc.
  • 12.6. 3M
  • 12.7. Den-Mat Holdings, LLC
  • 12.8. Dentsply Sirona
  • 12.9. Xttrium Laboratories, Inc.
  • 12.10. Dexcel Pharma

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us